Annual global biopharmaceutical manufacturing survey is on again
Tuesday, 18 December, 2012
Your input is more important than ever, as the researchers benchmark global and regional trends affecting our industry. You will receive a free summary of the results of this important global study.
The survey takes between 10-25 minutes, depending on your areas of expertise, and for each completed survey BioPlan Associates will donate $10 (up to $10,000) to global health charities.
Click here to participate.
The Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production yields a composite view and trend analysis from hundreds of responsible individuals at biopharmaceutical manufacturers and CMOs, in 31 countries. The methodology also encompasses an additional 200 direct suppliers of materials, services and equipment to this industry.
This survey covers such issues as: new product needs, facility budget changes, current capacity, future capacity constraints, expansions, use of disposables, trends and budgets in disposables, trends in downstream purification, quality management and control, hiring issues and employment.
The quantitative trend analysis provides details and comparisons of production by biotherapeutic developers and CMOs. It also evaluates trends over time, and assesses differences in the world's major markets.
For more information contact Donnie Elizabeth Gillespie, Project Director, BioPlan Associates.
Reproductive impacts of PFAS exposure revealed
New studies have found that PFAS exposure can significantly alter male reproductive health, and...
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
